• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Comprehensive therapy of bladder preservation for muscle invasive bladder cancer].

作者信息

Li Bolun, Li Yuan

机构信息

Department of Urology, Xiangya Hospital, Central South University, Changsha 410008, China.

出版信息

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018 Jan 28;43(1):82-89. doi: 10.11817/j.issn.1672-7347.2018.01.013.

DOI:10.11817/j.issn.1672-7347.2018.01.013
PMID:30154296
Abstract

The bladder cancer is a common malignant tumor in urinary system. The standard treatment for muscle invasive bladder cancer is radical cystectomy. Considering the damage to patients and the drastic effect on their life caused by the radical cystectomy, many domestic and overseas scholars suggest a comprehensive treatment based on a bladder-keeping surgery with adjuvant therapy including radiotherapy, chemotherapy and frequent follow-up, which showslow operation-related risk and complication rate compared with the radical cystectomy. As a result, patients are able to preserve the function of bladder.

摘要

相似文献

1
[Comprehensive therapy of bladder preservation for muscle invasive bladder cancer].
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018 Jan 28;43(1):82-89. doi: 10.11817/j.issn.1672-7347.2018.01.013.
2
Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.根治性膀胱切除术联合多模式治疗在肌层浸润性膀胱癌中的保膀胱作用的批判性分析:一项系统性综述。
Eur Urol. 2014 Jul;66(1):120-37. doi: 10.1016/j.eururo.2014.02.038. Epub 2014 Feb 26.
3
Can bladder preservation therapy come to the center stage?膀胱保留疗法能否成为核心治疗方法?
Int J Urol. 2018 Feb;25(2):134-140. doi: 10.1111/iju.13495. Epub 2017 Nov 23.
4
Bladder-sparing treatment of invasive bladder cancer.浸润性膀胱癌的膀胱保留治疗。
Cancer Control. 2000 Jul-Aug;7(4):340-6. doi: 10.1177/107327480000700403.
5
Trimodal therapy for muscle-invasive bladder cancer.肌层浸润性膀胱癌的三联疗法。
Expert Rev Anticancer Ther. 2018 Dec;18(12):1219-1229. doi: 10.1080/14737140.2018.1535314. Epub 2018 Oct 17.
6
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.保留膀胱的三联疗法治疗肌层浸润性膀胱癌患者的长期疗效:马萨诸塞州综合医院经验的更新分析。
Eur Urol. 2017 Jun;71(6):952-960. doi: 10.1016/j.eururo.2016.12.020. Epub 2017 Jan 9.
7
Bladder preservation strategies.膀胱保留策略。
Hematol Oncol Clin North Am. 2015 Apr;29(2):289-300, ix. doi: 10.1016/j.hoc.2014.10.004. Epub 2014 Dec 15.
8
Bladder-sparing approaches to invasive disease.针对浸润性疾病的膀胱保留方法。
World J Urol. 2006 Nov;24(5):517-29. doi: 10.1007/s00345-006-0114-y.
9
High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol.高Ki-67表达预示着接受基于放化疗的膀胱保留方案治疗的肌层浸润性膀胱癌患者有良好的生存率。
Clin Genitourin Cancer. 2015 Aug;13(4):e243-e251. doi: 10.1016/j.clgc.2015.03.002. Epub 2015 Mar 27.
10
Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions.肌肉浸润性膀胱癌的三联疗法:最新进展与未解决的问题
Curr Oncol Rep. 2020 Feb 1;22(2):14. doi: 10.1007/s11912-020-0880-5.